Literature DB >> 4809906

Inactivated Venezuelan equine encephalomyelitis vaccine prepared from attenuated (TC-83 strain) virus.

F E Cole, S W May, G A Eddy.   

Abstract

Formalin-inactivated Venezuelan equine encephalomyelitis vaccine was prepared from virus propagated in rolling-bottle cultures of chicken embryo cells. The attenuated, TC-83 strain of virus was propagated in these cultures with a maintenance medium consisting of serum-free medium 199 containing 0.25% human serum albumin and antibiotics. By adjustment of maintenance medium volume (100 to 300 ml) and multiplicity of inoculum (0.04 to 0.00004), high-titered yields of virus were obtained with minimal cell destruction at convenient harvest times, viz, 18 to 24 h postinoculation. Inactivation of virus at 37 C was complete between 8 to 10 h with 0.05% Formalin and within 6 to 8 h with 0.1% Formalin. Antigen extinction potency tests in mice indicated that potent vaccines could be produced at both Formalin concentrations and, furthermore, that potency was not adversely affected by inactivation periods of up to 96 h.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4809906      PMCID: PMC379984          DOI: 10.1128/am.27.1.150-153.1974

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  10 in total

1.  USE OF AN ATTENUATED STRAIN OF VENEZUELAN EQUINE ENCEPHALOMYELITIS VIRUS FOR IMMUNIZATION IN MAN.

Authors:  R W MCKINNEY; T O BERGE; W D SAWYER; W D TIGERTT; D CROZIER
Journal:  Am J Trop Med Hyg       Date:  1963-07       Impact factor: 2.345

2.  FATAL ENCEPHALITIS IN MAN DUE TO THE VENEZUELAN VIRUS OF EQUINE ENCEPHALOMYELITIS IN TRINIDAD.

Authors:  R Randall; J W Mills
Journal:  Science       Date:  1944-03-17       Impact factor: 47.728

3.  Isolation of the vaccine strain of Venezuelan equine encephalomyelitis virus from mosquitoes in Louisiana.

Authors:  C E Pedersen; D M Robinson; F E Cole
Journal:  Am J Epidemiol       Date:  1972-05       Impact factor: 4.897

4.  Studies on Japanese B encephalitis virus vaccines from tissue culture. 8. Formalin inactivated OCT-wild strain vaccine.

Authors:  M A Darwish; W M Hammon
Journal:  J Immunol       Date:  1966-10       Impact factor: 5.422

5.  Venezuelan equine encephalomyelitis in Central America and Mexico.

Authors:  R O Spertzel; R W McKinney
Journal:  Mil Med       Date:  1972-12       Impact factor: 1.437

6.  Formalin-inactivated Venezuelan equine encephalomyelitis (Trinidad strain) vaccine produced in rolling-bottle cultures of chicken embryo cells.

Authors:  F E Cole; S W May; D M Robinson
Journal:  Appl Microbiol       Date:  1973-02

7.  Use of hamsters of potency assay of Eastern and Western equine encephalitis vaccines.

Authors:  F E Cole; R W McKinney
Journal:  Appl Microbiol       Date:  1969-06

8.  Inactivated eastern equine encephalomyelitis vaccine propagated in rolling-bottle cultures of chick embryo cells.

Authors:  F E Cole
Journal:  Appl Microbiol       Date:  1971-11

9.  Homegeneity of Venezuelan encephalitis virion populations of hamster-virulent and benign strains, including the attenuated TC83 vaccine.

Authors:  P B Jahrling; W F Scherer
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

10.  Studies on Japanese B encephalitis virus vaccine from tissue culture. VI. Development of a hamster kidney tissue culture inactivated vaccine for man. 4. Preparation and characterization of vaccine lot for human trial.

Authors:  M A Darwish; W M Hammon
Journal:  Am J Trop Med Hyg       Date:  1966-09       Impact factor: 2.345

  10 in total
  14 in total

1.  Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.

Authors:  Jesse H Erasmus; Robert L Seymour; Jason T Kaelber; Dal Y Kim; Grace Leal; Michael B Sherman; Ilya Frolov; Wah Chiu; Scott C Weaver; Farooq Nasar
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

2.  Adjuvant effects of low doses of a nuclease-resistant derivative of polyinosinic acid . polycytidylic acid on antibody responses of monkeys to inactivated Venezuelan equine encephalomyelitis virus vaccine.

Authors:  D G Harrington; C L Crabbs; D E Hilmas; J R Brown; G A Higbee; F E Cole; H B Levy
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

3.  Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus.

Authors:  Shannon S Martin; Russell R Bakken; Cathleen M Lind; Patricia Garcia; Erin Jenkins; Pamela J Glass; Michael D Parker; Mary Kate Hart; Donald L Fine
Journal:  Vaccine       Date:  2010-03-01       Impact factor: 3.641

4.  A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV).

Authors:  Donald L Fine; Erin Jenkins; Shannon S Martin; Pamela Glass; Michael D Parker; Brad Grimm
Journal:  J Virol Methods       Date:  2009-11-10       Impact factor: 2.014

5.  Adjuvant effects of diethylaminoethyl-dextran.

Authors:  W E Houston; C L Crabbs; R J Kremer; J W Springer
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

6.  Modified polyriboinosinic-polyribocytidylic acid, an immunological adjuvant.

Authors:  W E Houston; C L Crabbs; E L Stephen; H B Levy
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

7.  Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters.

Authors:  P B Jahrling; E H Stephenson
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

8.  Glucan-induced enhancement of host resistance to selected infectious diseases.

Authors:  J A Reynolds; M D Kastello; D G Harrington; C L Crabbs; C J Peters; J V Jemski; G H Scott; N R Di Luzio
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

9.  Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia.

Authors:  M S Ascher; P B Jahrling; D G Harrington; R A Kishimoto; V G McGann
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

10.  Kinetic, Mutational, and Structural Studies of the Venezuelan Equine Encephalitis Virus Nonstructural Protein 2 Cysteine Protease.

Authors:  Xin Hu; Jaimee R Compton; Dagmar H Leary; Mark A Olson; Michael S Lee; Jonah Cheung; Wenjuan Ye; Mark Ferrer; Noel Southall; Ajit Jadhav; Elaine M Morazzani; Pamela J Glass; Juan Marugan; Patricia M Legler
Journal:  Biochemistry       Date:  2016-05-19       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.